Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

ADVERTISEMENT

DNA Can be Read Either Forwards or Backwards

A new study reveals that bacterial DNA can be read either forwards or backwards due to the presence of symmetry in their DNA signals1. This finding challenges the existing knowledge about gene transcription, the mechanism by which the genes are transcribed to messenger RNA before they are translated into proteins.

The transcription of genes normally requires the presence of a promoter region before the start of the gene that is responsible for the transcriptional initiation of a particular gene and a terminator region required for stopping the transcription to ensure intactness of the full-length transcript. These promoter and terminator regions are usually unidirectional in nature and are involved in transcribing the gene in the forward direction. In the current study led by Professor David Grainger and colleagues at the University of Birmingham, it was revealed that 19% of transcriptional start sites in E. coli are associated with a bidirectional promoter. These bidirectional promoters are common in bacteria and archaea and possess symmetry in such a manner that the bases required for transcription initiation are present on both the strands of DNA as opposed to on the single strand. It has already been shown in bacteria that the terminator regions are bidirectional in nature2.

The implications of bidirectional transcription initiation are currently unclear and warrants further research and investigation. Does that mean that more information can be transcribed from a limited region of the genome or it helps to avoid reading collisions with other sequences? Or does it suggest additional regulatory mechanisms to control gene transcription. The next step would be to do research and investigate this mechanism in yeast, a single celled eukaryote.

The finding of bidirectional transcription can have immense implications in the field of biotechnology and healthcare as modern medicine is significantly dependent on how to modulate genes to switch them on and off, thereby alleviating the disease.

***

References

  1. Warman, E. A., et al. Widespread divergent transcription from bacterial and archaeal promoters is a consequence of DNA-sequence symmetry. 2021 Nature Microbiology. DOI: https://doi.org/10.1038/s41564-021-00898-9
  2. Ju X, Li D and Liu S. Full-length RNA profiling reveals pervasive bidirectional transcription terminators in bacteria. Nat Microbiol 4, 1907–1918 (2019). DOI: https://doi.org/10.1038/s41564-019-0500-z
Rajeev Soni
Rajeev Sonihttps://www.RajeevSoni.org/
Dr. Rajeev Soni (ORCID ID : 0000-0001-7126-5864) has a Ph.D. in Biotechnology from the University of Cambridge, UK and has 25 years of experience working across the globe in various institutes and multinationals such as The Scripps Research Institute, Novartis, Novozymes, Ranbaxy, Biocon, Biomerieux and as a principal investigator with US Naval Research Lab in drug discovery, molecular diagnostics, protein expression, biologic manufacturing and business development.

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Most Popular Articles

Kākāpō Parrot: Genomic sequencing benefits Conservation programme

Kākāpō parrot (also known as “owl parrot” because of...

B.1.1.529 variant named Omicron, designated as a Variant of concern (VOC) by WHO

WHO’s Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) was...

SARAH: WHO’s first generative AI-based Tool for Health Promotion  

In order to harness generative AI for public health,...
- Advertisement -
93,100FansLike
47,342FollowersFollow
1,772FollowersFollow
30SubscribersSubscribe